Inflarx NV (IFRX) is near the middle in its industry group according to InvestorsObserver. IFRX gets an overall rating of 41. That means it scores higher than 41 percent of stocks. Inflarx NV gets a 46 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Inflarx NV Stock Today?
Inflarx NV (IFRX) stock has fallen -1.99% while the S&P 500 is higher by 0.38% as of 12:14 PM on Thursday, Mar 4. IFRX is lower by -$0.08 from the previous closing price of $4.03 on volume of 325,945 shares. Over the past year the S&P 500 has risen 22.50% while IFRX is lower by -12.61%. IFRX lost -$1.77 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Inflarx NV (IFRX) Stock.
